The Catalan pharmaceutical company Almirall earned €4.3 million in 2022 and surpassed the losses of €40.9 million it had in 2021. The normalized net result, which...
Following these results, Almirall has confirmed its financial estimates for 2022. Investment in research and development (R&D) increased by 11.3% in the period, to €71.6 million...